$CVS
CVS HEALTH Corp

2019 Q4 Form 10-Q Financial Statement

#000006480319000049 Filed on November 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q1
Revenue $66.89B $64.81B $61.65B
YoY Change 22.9% 36.47% 34.77%
Cost Of Revenue $42.07B $40.44B $37.25B
YoY Change 10.22% 2.37% -0.69%
Gross Profit $24.82B $24.37B $24.40B
YoY Change 48.26% 205.12% 196.18%
Gross Profit Margin 37.11% 37.61% 39.58%
Selling, General & Admin $8.394B $8.550B $8.142B
YoY Change 26.93% 71.86% 65.72%
% of Gross Profit 33.81% 35.08% 33.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.111B
YoY Change 72.52%
% of Gross Profit 4.55%
Operating Expenses $21.53B $8.595B $8.250B
YoY Change 63.0% 72.76% 67.92%
Operating Profit $3.037B $2.928B $2.690B
YoY Change 268.57% 13.75% 34.77%
Interest Expense -$734.0M $747.0M $782.0M
YoY Change -39.74% 10.83% 49.52%
% of Operating Profit -24.17% 25.51% 29.07%
Other Income/Expense, Net $31.00M $31.00M $31.00M
YoY Change 181.82% -3200.0% 933.33%
Pretax Income $2.334B $2.133B $1.939B
YoY Change 2188.24% 12.32% 31.9%
Income Tax $590.0M $604.0M $512.0M
% Of Pretax Income 25.28% 28.32% 26.41%
Net Earnings $1.747B $1.530B $1.421B
YoY Change -516.95% 10.07% 42.38%
Net Earnings / Revenue 2.61% 2.36% 2.31%
Basic Earnings Per Share $1.34 $1.17 $1.09
Diluted Earnings Per Share $1.33 $1.17 $1.09
COMMON SHARES
Basic Shares Outstanding 1.301B shares 1.302B shares 1.298B shares
Diluted Shares Outstanding 1.305B shares 1.302B shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.056B $7.527B $8.322B
YoY Change 25.52% -81.95% -80.25%
Cash & Equivalents $5.683B $5.193B $5.896B
Short-Term Investments $2.373B $2.334B $2.426B
Other Short-Term Assets $5.113B $4.841B $4.533B
YoY Change 11.61% 663.56% 422.24%
Inventory $17.52B $16.03B $15.45B
Prepaid Expenses
Receivables $19.62B $19.79B $19.51B
Other Receivables $2.381B $2.007B $868.0M
Total Short-Term Assets $50.30B $48.19B $45.20B
YoY Change 11.18% -33.06% -37.05%
LONG-TERM ASSETS
Property, Plant & Equipment $12.04B $11.65B $11.36B
YoY Change 6.12% 11.82% 11.99%
Goodwill $79.75B $79.55B $79.08B
YoY Change 1.36%
Intangibles $33.12B $33.66B $36.31B
YoY Change -9.32%
Long-Term Investments $17.31B $17.34B $16.41B
YoY Change 10.06%
Other Assets $4.600B $4.385B $4.525B
YoY Change -8.84% 154.35% 167.12%
Total Long-Term Assets $172.1B $171.9B $171.5B
YoY Change 13.84% 188.83% 170.71%
TOTAL ASSETS
Total Short-Term Assets $50.30B $48.19B $45.20B
Total Long-Term Assets $172.1B $171.9B $171.5B
Total Assets $222.4B $220.1B $216.7B
YoY Change 13.23% 67.38% 60.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.97B $29.56B $26.82B
YoY Change 17.15% 39.67% 41.28%
Accrued Expenses $12.13B $11.62B $10.66B
YoY Change 13.28% 88.56% 38.0%
Deferred Revenue $73.00M $72.00M $75.00M
YoY Change 8.96%
Short-Term Debt $0.00 $1.070B $3.005B
YoY Change -100.0%
Long-Term Debt Due $3.781B $3.778B $1.267B
YoY Change 198.89% 76.62% -64.23%
Total Short-Term Liabilities $53.30B $52.54B $45.76B
YoY Change 21.12% 78.36% 51.29%
LONG-TERM LIABILITIES
Long-Term Debt $64.70B $64.21B $71.35B
YoY Change -9.44% 5.69% 15.91%
Other Long-Term Liabilities $2.162B $2.178B $2.262B
YoY Change -22.23% 34.03% 41.02%
Total Long-Term Liabilities $66.86B $66.38B $73.61B
YoY Change -9.92% 6.43% 16.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.30B $52.54B $45.76B
Total Long-Term Liabilities $66.86B $66.38B $73.61B
Total Liabilities $158.3B $157.2B $157.9B
YoY Change 14.77% 65.65% 63.73%
SHAREHOLDERS EQUITY
Retained Earnings $45.11B $44.02B $41.09B
YoY Change 10.26%
Common Stock $17.00M $17.00M $17.00M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $28.24B $28.21B $28.22B
YoY Change 0.02%
Treasury Stock Shares 425.0M shares 424.0M shares 424.0M shares
Shareholders Equity $63.86B $62.61B $58.40B
YoY Change
Total Liabilities & Shareholders Equity $222.4B $220.1B $219.8B
YoY Change 13.23% 67.38% 62.62%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q1
OPERATING ACTIVITIES
Net Income $1.747B $1.530B $1.421B
YoY Change -516.95% 10.07% 42.38%
Depreciation, Depletion And Amortization $1.111B
YoY Change 72.52%
Cash From Operating Activities $2.634B $2.928B $1.948B
YoY Change 6.25% 166.91% -17.28%
INVESTING ACTIVITIES
Capital Expenditures -$567.0M -$601.0M $716.0M
YoY Change -3.08% 11.3% 48.55%
Acquisitions $124.0M
YoY Change -64.87%
Other Investing Activities -$142.0M -$228.0M -$10.00M
YoY Change -99.66% 142.55% -600.0%
Cash From Investing Activities -$709.0M -$829.0M -$891.0M
YoY Change -98.31% 30.76% 580.15%
FINANCING ACTIVITIES
Cash Dividend Paid $649.0M
YoY Change 27.76%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $882.0M
YoY Change 88100.0%
Cash From Financing Activities -1.440B -2.968B $816.0M
YoY Change -176.11% 10.21% -97.86%
NET CHANGE
Cash From Operating Activities 2.634B 2.928B $1.948B
Cash From Investing Activities -709.0M -829.0M -$891.0M
Cash From Financing Activities -1.440B -2.968B $816.0M
Net Change In Cash 485.0M -869.0M $1.873B
YoY Change -101.29% -61.03% -95.36%
FREE CASH FLOW
Cash From Operating Activities $2.634B $2.928B $1.948B
Capital Expenditures -$567.0M -$601.0M $716.0M
Free Cash Flow $3.201B $3.529B $1.232B
YoY Change 4.47% 115.58% -34.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 cvs Four Years Reinsurance Agreement With Unrelated Insurer
FourYearsReinsuranceAgreementWithUnrelatedInsurer
P4Y
CY2017Q4 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2018Q1 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2018Q2 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2018Q4 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2019Q1 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2019Q2 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2017Q4 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
31000000 USD
CY2018Q1 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
31000000 USD
CY2018Q4 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
CY2019Q1 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
CY2019Q2 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
dei Entity Address Address Line1
EntityAddressAddressLine1
One CVS Drive,
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.5
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1301000000 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1720000000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1295000000 shares
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2018Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0 USD
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
0 USD
us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
0 USD
CY2019Q3 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
0 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
425000000 shares
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
424000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-01011
dei Entity Registrant Name
EntityRegistrantName
CVS HEALTH CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0494040
dei Entity Address City Or Town
EntityAddressCityOrTown
Woonsocket,
dei Entity Address State Or Province
EntityAddressStateOrProvince
RI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02895
dei City Area Code
CityAreaCode
(401)
dei Local Phone Number
LocalPhoneNumber
765-1500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
CVS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1300964007 shares
CY2019Q3 us-gaap Net Investment Income
NetInvestmentIncome
263000000 USD
CY2018Q3 us-gaap Net Investment Income
NetInvestmentIncome
221000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
805000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
485000000 USD
CY2019Q3 us-gaap Revenues
Revenues
64810000000 USD
CY2018Q3 us-gaap Revenues
Revenues
47490000000 USD
us-gaap Revenues
Revenues
189887000000 USD
us-gaap Revenues
Revenues
140155000000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40437000000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39502000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
116654000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115883000000 USD
CY2019Q3 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
12850000000 USD
CY2018Q3 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
439000000 USD
us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
39396000000 USD
us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
2399000000 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3921000000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
8595000000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
4975000000 USD
us-gaap Operating Expenses
OperatingExpenses
24887000000 USD
us-gaap Operating Expenses
OperatingExpenses
14755000000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
61882000000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
44916000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
180937000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2928000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
136958000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-79000000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2574000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8950000000 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-79000000 USD
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3197000000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
747000000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
674000000 USD
us-gaap Interest Expense
InterestExpense
2301000000 USD
us-gaap Interest Expense
InterestExpense
1886000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
93000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2133000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1899000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6663000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1304000000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
604000000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
509000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1776000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1478000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1529000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1390000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4887000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-174000000 USD
CY2019Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2018Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
1529000000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
1390000000 USD
us-gaap Profit Loss
ProfitLoss
4887000000 USD
us-gaap Profit Loss
ProfitLoss
-175000000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1530000000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1390000000 USD
us-gaap Net Income Loss
NetIncomeLoss
4887000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-175000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.17
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.36
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.76
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2019Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2018Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1302000000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1020000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1300000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1018000000 shares
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.17
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.36
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.75
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2019Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2018Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.17
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1305000000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1022000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1303000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1018000000 shares
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2019Q3 us-gaap Profit Loss
ProfitLoss
1529000000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
1390000000 USD
us-gaap Profit Loss
ProfitLoss
4887000000 USD
us-gaap Profit Loss
ProfitLoss
-175000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
136000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
721000000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
157000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-23000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-4000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-30000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
335000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
266000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
848000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
301000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1795000000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1378000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5735000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
126000000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1796000000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1378000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5735000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126000000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5193000000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4059000000 USD
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
2334000000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2522000000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19789000000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17631000000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
16028000000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
16450000000 USD
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4841000000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4581000000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
48185000000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
45243000000 USD
CY2019Q3 us-gaap Long Term Investments
LongTermInvestments
17342000000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
15732000000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11651000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11349000000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20757000000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
79548000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
78678000000 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33655000000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36524000000 USD
CY2019Q3 us-gaap Separate Account Assets
SeparateAccountAssets
4590000000 USD
CY2018Q4 us-gaap Separate Account Assets
SeparateAccountAssets
3884000000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4385000000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5046000000 USD
CY2019Q3 us-gaap Assets
Assets
220113000000 USD
CY2018Q4 us-gaap Assets
Assets
196456000000 USD
CY2019Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9442000000 USD
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8925000000 USD
CY2019Q3 cvs Pharmacy Claimsand Discounts Payable Current
PharmacyClaimsandDiscountsPayableCurrent
13099000000 USD
CY2018Q4 cvs Pharmacy Claimsand Discounts Payable Current
PharmacyClaimsandDiscountsPayableCurrent
11365000000 USD
CY2019Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
7014000000 USD
CY2018Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
6147000000 USD
CY2019Q3 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
2938000000 USD
CY2018Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
2939000000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11615000000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10711000000 USD
CY2019Q3 cvs Other Insurance Liabilities Current
OtherInsuranceLiabilitiesCurrent
1790000000 USD
CY2018Q4 cvs Other Insurance Liabilities Current
OtherInsuranceLiabilitiesCurrent
1937000000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1798000000 USD
CY2019Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1070000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3778000000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1265000000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
52544000000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44009000000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18826000000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
64206000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71444000000 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7279000000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7677000000 USD
CY2019Q3 us-gaap Separate Accounts Liability
SeparateAccountsLiability
4590000000 USD
CY2018Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
3884000000 USD
CY2019Q3 cvs Other Insurance Liabilities Noncurrent
OtherInsuranceLiabilitiesNoncurrent
7557000000 USD
CY2018Q4 cvs Other Insurance Liabilities Noncurrent
OtherInsuranceLiabilitiesNoncurrent
8119000000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2178000000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2780000000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
157180000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
137913000000 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
45854000000 USD
CY2018Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
45440000000 USD
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
28207000000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
28228000000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
44017000000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40911000000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
950000000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
62614000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
58225000000 USD
CY2019Q3 us-gaap Minority Interest
MinorityInterest
319000000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
318000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62933000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220113000000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
196456000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
184519000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
132275000000 USD
cvs Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies
PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
109958000000 USD
cvs Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies
PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
107920000000 USD
cvs Paymentsfor Insurance Benefits
PaymentsforInsuranceBenefits
38812000000 USD
cvs Paymentsfor Insurance Benefits
PaymentsforInsuranceBenefits
2400000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
21411000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
12305000000 USD
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
756000000 USD
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
406000000 USD
us-gaap Interest Paid Net
InterestPaidNet
2675000000 USD
us-gaap Interest Paid Net
InterestPaidNet
1759000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2205000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1911000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10214000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6386000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5616000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
43000000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6011000000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
97000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1890000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1452000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
361000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
616000000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
725000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-16000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-11000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2630000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1386000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
350000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1276000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3458000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
39376000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8350000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2266000000 USD
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
25000000 USD
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-446000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1952000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1528000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
183000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
214000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
39000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6410000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34927000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1174000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39927000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4295000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1900000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5469000000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41827000000 USD
us-gaap Profit Loss
ProfitLoss
4887000000 USD
us-gaap Profit Loss
ProfitLoss
-175000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3275000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1911000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3921000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
355000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
172000000 USD
us-gaap Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax
DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax
205000000 USD
us-gaap Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax
DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax
86000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-79000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
cvs Deferredincometaxesandothernoncashitems
Deferredincometaxesandothernoncashitems
-38000000 USD
cvs Deferredincometaxesandothernoncashitems
Deferredincometaxesandothernoncashitems
210000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2312000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1725000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-413000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-472000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
374000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2330000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1839000000 USD
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
535000000 USD
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
0 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
859000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-322000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10214000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6386000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2019Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1427000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
331000000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
175000000 USD
CY2019Q1 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
-7000000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
651000000 USD
CY2019Q1 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
-4000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60006000000 USD
CY2019Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1931000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
251000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
104000000 USD
CY2019Q2 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
36000000 USD
CY2019Q2 us-gaap Dividends Common Stock
DividendsCommonStock
659000000 USD
CY2019Q2 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
2000000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61599000000 USD
CY2019Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1529000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
266000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
266000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000000 USD
CY2019Q3 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
-50000000 USD
CY2019Q3 us-gaap Dividends Common Stock
DividendsCommonStock
649000000 USD
CY2019Q3 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
3000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62933000000 USD
CY2019Q3 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2019Q3 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37695000000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-13000000 USD
CY2018Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
998000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
344000000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
112000000 USD
CY2018Q1 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
-49000000 USD
CY2018Q1 us-gaap Dividends Common Stock
DividendsCommonStock
508000000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38677000000 USD
CY2018Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2563000000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-31000000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
73000000 USD
CY2018Q2 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
33000000 USD
CY2018Q2 us-gaap Dividends Common Stock
DividendsCommonStock
512000000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35611000000 USD
CY2018Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1390000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
96000000 USD
CY2018Q3 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
-49000000 USD
CY2018Q3 us-gaap Dividends Common Stock
DividendsCommonStock
512000000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36622000000 USD
CY2018Q3 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2018Q3 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
CY2018Q2 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
31000000 USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2019Q3 us-gaap Number Of Stores
NumberOfStores
9900 building
CY2019Q3 cvs Numberof Walk In Medical Clinics
NumberofWalkInMedicalClinics
1100 clinic
CY2019Q3 cvs Numberof Pharmacy Plan Members
NumberofPharmacyPlanMembers
102000000 person
CY2019Q3 cvs Numberof Patients Servedper Year
NumberofPatientsServedperYear
1000000 patient
CY2019Q3 cvs Numberof People Servedthrough Health Insurance Productsand Related Services
NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices
38000000 person
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 Segment
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div>
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5193000000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4059000000 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
6000000 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6000000 USD
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
270000000 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
230000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5469000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4295000000 USD
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6413000000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6497000000 USD
CY2019Q3 cvs Vendorand Manufacturer Receivables
VendorandManufacturerReceivables
9029000000 USD
CY2018Q4 cvs Vendorand Manufacturer Receivables
VendorandManufacturerReceivables
7315000000 USD
CY2019Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
2340000000 USD
CY2018Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
2259000000 USD
CY2019Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2007000000 USD
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1560000000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19789000000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17631000000 USD
CY2019Q3 us-gaap Net Investment Income
NetInvestmentIncome
263000000 USD
CY2019Q3 us-gaap Revenues
Revenues
64810000000 USD
CY2018Q3 us-gaap Net Investment Income
NetInvestmentIncome
221000000 USD
CY2018Q3 us-gaap Revenues
Revenues
47490000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
805000000 USD
us-gaap Revenues
Revenues
189887000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
485000000 USD
us-gaap Revenues
Revenues
140155000000 USD
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6413000000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6497000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
72000000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67000000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67000000 USD
cvs Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance
ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
269000000 USD
cvs Contractwith Customer Liaiblity Redemptionand Breakage
ContractwithCustomerLiaiblityRedemptionandBreakage
-264000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
72000000 USD
CY2019Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
14000000 USD
CY2018Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4000000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
26000000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
34000000 USD
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
72000000 USD
CY2019Q3 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
20000000 USD
CY2018Q3 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
34000000 USD
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
105000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4581000000 USD
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
4533000000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
45243000000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
45195000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11349000000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11360000000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20987000000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36524000000 USD
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36307000000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5046000000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4525000000 USD
CY2018Q4 us-gaap Assets
Assets
196456000000 USD
CY2019Q1 us-gaap Assets
Assets
216668000000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10711000000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10659000000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1803000000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1265000000 USD
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1267000000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44009000000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
45762000000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18832000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71444000000 USD
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71348000000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7677000000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7740000000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2780000000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2262000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
137913000000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
157947000000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40911000000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
41089000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
58225000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
58403000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58721000000 USD
CY2018Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
60865000000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
180164000000 USD
CY2018Q3 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
1864000000 USD
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
1731000000 USD
CY2018Q3 us-gaap Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic
1.44
us-gaap Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic
1.34
CY2018Q3 us-gaap Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Diluted
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted
1.43
us-gaap Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Diluted
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted
1.33
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
2334000000 USD
CY2019Q3 us-gaap Long Term Investments
LongTermInvestments
17342000000 USD
CY2019Q3 us-gaap Investments
Investments
19676000000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2522000000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
15732000000 USD
CY2018Q4 us-gaap Investments
Investments
18254000000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15708000000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1063000000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
16758000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15119000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
172000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
36000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15255000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1017000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1022000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5378000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5568000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3098000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
3316000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
3693000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4239000000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15708000000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
16758000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
648 security
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
790000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
13000000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
2279 security
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2409000000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
36000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
3000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After One Through Five Years
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterOneThroughFiveYears
138000000 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After One Through Five Years Accumulated Loss
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterOneThroughFiveYearsAccumulatedLoss
2000000 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After Five Through Ten Years
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterFiveThroughTenYears
136000000 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After Five Through Ten Years Accumulated Loss
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterFiveThroughTenYearsAccumulatedLoss
4000000 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After Ten Years
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterTenYears
110000000 USD
CY2019Q3 cvs Debt Securities Availableforsale Continuous Unrealized Loss Position After Ten Years Accumulated Loss
DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionAfterTenYearsAccumulatedLoss
2000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
790000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
13000000 USD
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
224000000 USD
CY2018Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
221000000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
654000000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
485000000 USD
CY2019Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
10000000 USD
CY2018Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
0 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
28000000 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
0 USD
CY2019Q3 cvs Investment Income Excluding Capital Gainsor Losses
InvestmentIncomeExcludingCapitalGainsorLosses
214000000 USD
CY2018Q3 cvs Investment Income Excluding Capital Gainsor Losses
InvestmentIncomeExcludingCapitalGainsorLosses
221000000 USD
cvs Investment Income Excluding Capital Gainsor Losses
InvestmentIncomeExcludingCapitalGainsorLosses
626000000 USD
cvs Investment Income Excluding Capital Gainsor Losses
InvestmentIncomeExcludingCapitalGainsorLosses
485000000 USD
CY2019Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
49000000 USD
CY2018Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
179000000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
263000000 USD
CY2018Q3 us-gaap Investment Income Net
InvestmentIncomeNet
221000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
805000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
485000000 USD
CY2019Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
9000000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
13000000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
681000000 USD
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
22000000 USD
CY2019Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1325000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4087000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
55000000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
127000000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
9000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2044000000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9000000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
27000000 USD
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
32000000 USD
CY2019Q3 cvs Finance Lease Cost
FinanceLeaseCost
20000000 USD
cvs Finance Lease Cost
FinanceLeaseCost
59000000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
17000000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
148000000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
434000000 USD
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
13000000 USD
us-gaap Sublease Income
SubleaseIncome
35000000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
841000000 USD
us-gaap Lease Cost
LeaseCost
2519000000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2023000000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
32000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
19000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1203000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
82000000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20757000000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1798000000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18826000000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20624000000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
560000000 USD
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
27000000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
591000000 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
618000000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y9M18D
CY2019Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P20Y7M6D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.046
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.073
CY2019Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
18000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
679000000 USD
CY2019Q3 cvs Lessee Liability Payments Remainderof Fiscal Year
LesseeLiabilityPaymentsRemainderofFiscalYear
697000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
70000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2688000000 USD
CY2019Q3 cvs Lessee Liability Payments Due Year Two
LesseeLiabilityPaymentsDueYearTwo
2758000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
68000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2567000000 USD
CY2019Q3 cvs Lessee Liability Payments Due Year Three
LesseeLiabilityPaymentsDueYearThree
2635000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
64000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2408000000 USD
CY2019Q3 cvs Lessee Liability Payments Due Year Four
LesseeLiabilityPaymentsDueYearFour
2472000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
62000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2297000000 USD
CY2019Q3 cvs Lessee Liability Payments Due Year Five
LesseeLiabilityPaymentsDueYearFive
2359000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
883000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
17165000000 USD
CY2019Q3 cvs Lessee Liability Payments Due After Year Five
LesseeLiabilityPaymentsDueAfterYearFive
18048000000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1165000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
27804000000 USD
CY2019Q3 cvs Lessee Liability Payments Due
LesseeLiabilityPaymentsDue
28969000000 USD
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
547000000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7180000000 USD
CY2019Q3 cvs Lessee Liability Undiscounted Excess Amount
LesseeLiabilityUndiscountedExcessAmount
7727000000 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
618000000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20624000000 USD
CY2019Q3 cvs Lease Liability
LeaseLiability
21242000000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3778000000 USD
CY2019Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
320000000 USD
CY2019Q3 cvs Operating And Capital Leases Amount Due In Excess Of Remaining Estimated Economic Life
OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife
2300000000 USD
us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
5000000 USD
us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;">The following table shows the components of the change in health care costs payable during the </span><span style="font-family:Times New Roman;font-size:10pt;">nine months ended</span><span style="font-family:Times New Roman;font-size:10pt;"> </span><span style="font-family:Times New Roman;font-size:10pt;">September 30, 2019</span><span style="font-family:Times New Roman;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:89%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;text-decoration:underline;">In millions</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, beginning of the period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,147</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Reinsurance recoverables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, beginning of the period, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,143</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Components of incurred health care costs</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,657</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(511</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total incurred health care costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39,146</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Claims paid</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,032</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,253</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total claims paid</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,285</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Premium deficiency reserve</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, end of period, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,010</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Reinsurance recoverables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,014</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Times New Roman;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">_____________________________________________</sup> </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;vertical-align:bottom;font-size:8pt;padding-left:0px;"><span style="font-family:Times New Roman;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;vertical-align:bottom;font-size:8pt;"><span style="font-family:Times New Roman;font-size:8pt;">Total incurred health care costs during the </span><span style="font-family:Times New Roman;font-size:8pt;">nine months ended</span><span style="font-family:Times New Roman;font-size:8pt;"> </span><span style="font-family:Times New Roman;font-size:8pt;">September 30, 2019</span><span style="font-family:Times New Roman;font-size:8pt;"> in the table above exclude (i) </span><span style="font-family:Times New Roman;font-size:8pt;"><span>$6 million</span></span><span style="font-family:Times New Roman;font-size:8pt;"> related to a premium deficiency reserve for the 2019 coverage year related to the Company’s Medicaid products, (ii) </span><span style="font-family:Times New Roman;font-size:8pt;"><span>$31 million</span></span><span style="font-family:Times New Roman;font-size:8pt;"> of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheet and (iii) </span><span style="font-family:Times New Roman;font-size:8pt;"><span>$213 million</span></span><span style="font-family:Times New Roman;font-size:8pt;"> of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheet.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div>
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-511000000 USD
CY2019Q3 us-gaap Shortduration Insurance Contracts Incurred But Not Reported Ibnr Claims Liability Net
ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
5000000000.0 USD
CY2019Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1070000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
69848000000 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
74265000000 USD
CY2019Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
267000000 USD
CY2018Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
302000000 USD
CY2019Q3 cvs Debt Instrument Unamortized Discountand Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
1061000000 USD
CY2018Q4 cvs Debt Instrument Unamortized Discountand Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
1138000000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
69054000000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
73429000000 USD
CY2019Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1070000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1265000000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
64206000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71444000000 USD
CY2019Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
3500000000 USD
CY2019Q3 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
25000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
18000000 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-76000000 USD
CY2019Q3 cvs Debt Extinguishment Fees
DebtExtinguishmentFees
8000000 USD
CY2019Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
5000000 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-79000000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1529000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1390000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
266000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
848000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
301000000 USD
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000000 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000000 shares
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4887000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-174000000 USD
CY2019Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
0 USD
CY2018Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
1000000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1530000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1389000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4884000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-177000000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1302000000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1020000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1300000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1018000000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1305000000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1022000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1303000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1018000000 shares
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.17
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.36
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.76
CY2018Q3 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
439000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.17
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.36
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.75
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2019Q1 cvs Numberof Reinsurance Contracts Entered Into
NumberofReinsuranceContractsEnteredInto
2 agreement
CY2019Q3 cvs Guarantor Obligations Numberof Leases
GuarantorObligationsNumberofLeases
79 store
CY2015Q3 cvs Loss Contingency Number Of Locations With Subpoena For Documents
LossContingencyNumberOfLocationsWithSubpoenaForDocuments
8 store
CY2012 cvs Loss Contingency Audit Methodology Sample Size
LossContingencyAuditMethodologySampleSize
200 memeber
us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
6 claim
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 Segment
CY2018Q3 us-gaap Revenues
Revenues
47490000000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39502000000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
4975000000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2574000000 USD
CY2018Q3 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
2650000000 USD
us-gaap Revenues
Revenues
140155000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115883000000 USD
us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
2399000000 USD
us-gaap Operating Expenses
OperatingExpenses
14755000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3197000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
7542000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64547000000 USD
CY2019Q3 us-gaap Net Investment Income
NetInvestmentIncome
263000000 USD
CY2019Q3 us-gaap Revenues
Revenues
64810000000 USD
CY2019Q3 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
3947000000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47269000000 USD
CY2018Q3 us-gaap Net Investment Income
NetInvestmentIncome
221000000 USD
CY2018Q3 us-gaap Revenues
Revenues
47490000000 USD
CY2018Q3 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
2650000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189082000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
805000000 USD
us-gaap Revenues
Revenues
189887000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11573000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139670000000 USD
us-gaap Net Investment Income
NetInvestmentIncome
485000000 USD
us-gaap Revenues
Revenues
140155000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
7542000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2928000000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2574000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8950000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3197000000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
607000000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
215000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1822000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
639000000 USD
CY2019Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
111000000 USD
CY2018Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
70000000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
365000000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
152000000 USD
CY2019Q3 cvs Store Rationalization Charges
StoreRationalizationCharges
96000000 USD
CY2018Q3 cvs Store Rationalization Charges
StoreRationalizationCharges
0 USD
cvs Store Rationalization Charges
StoreRationalizationCharges
231000000 USD
cvs Store Rationalization Charges
StoreRationalizationCharges
0 USD
CY2019Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-205000000 USD
CY2018Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-205000000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-86000000 USD
CY2019Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2018Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3921000000 USD
CY2019Q3 cvs Net Interest Income Financing Of Aetna Acquisition
NetInterestIncomeFinancingOfAetnaAcquisition
0 USD
CY2018Q3 cvs Net Interest Income Financing Of Aetna Acquisition
NetInterestIncomeFinancingOfAetnaAcquisition
209000000 USD
cvs Net Interest Income Financing Of Aetna Acquisition
NetInterestIncomeFinancingOfAetnaAcquisition
0 USD
cvs Net Interest Income Financing Of Aetna Acquisition
NetInterestIncomeFinancingOfAetnaAcquisition
453000000 USD
CY2019Q3 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
3947000000 USD
CY2018Q3 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
2650000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11573000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
7542000000 USD

Files In Submission

Name View Source Status
0000064803-19-000049-index-headers.html Edgar Link pending
0000064803-19-000049-index.html Edgar Link pending
0000064803-19-000049.txt Edgar Link pending
0000064803-19-000049-xbrl.zip Edgar Link pending
a0930201910-q.htm Edgar Link pending
a0930201910-q_htm.xml Edgar Link completed
a09302019ex151.htm Edgar Link pending
a09302019ex311.htm Edgar Link pending
a09302019ex312.htm Edgar Link pending
a09302019ex321.htm Edgar Link pending
a09302019ex322.htm Edgar Link pending
cvs-20190930.xsd Edgar Link pending
cvs-20190930_cal.xml Edgar Link unprocessable
cvs-20190930_def.xml Edgar Link unprocessable
cvs-20190930_lab.xml Edgar Link unprocessable
cvs-20190930_pre.xml Edgar Link unprocessable
cvshealtha19.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending